Mike Crapo actually said...

When we talk about the need for greater transparency in the drug supply chain, that term can and should mean a few different things.

We need to identify avenues for lowering out-of-pocket costs, increasing competition, and promoting access to lifesaving innovation--and we ...

I have long championed efforts to improve prescription drug access and affordability for Americans, and I welcome the opportunity to engage ...

We have got to figure out how to strengthen Medicare.